JTWM
BMY icon

Jackson Thornton Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Jackson Thornton Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
24,271
+3,975
+20% +$232K 0.13% 45
2025
Q4 		$1.1M Buy
20,296
+14,091
+227% +$678K 0.1% 53
2025
Q3 		$276K Buy
+6,205
New +$290K 0.03% 201

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jackson Thornton Wealth Management's BMY Position: Q1 2026 in Review

Jackson Thornton Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, buying an estimated $232K and bringing the position to 24,271 shares worth $1.42M. The position accounts for 0.13% of the portfolio, ranked #45.

Jackson Thornton Wealth Management first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Jackson Thornton Wealth Management held 24,271 shares of Bristol-Myers Squibb worth $1.42M as of Q1 2026.
  • Jackson Thornton Wealth Management bought 3,975 Bristol-Myers Squibb shares in Q1 2026, an estimated $232K.
  • Bristol-Myers Squibb made up 0.13% of Jackson Thornton Wealth Management's portfolio in Q1 2026, its #45 holding.
  • Jackson Thornton Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.